The Guardian reports:
- A member of the European Patients Forum and an umbrella body for national Alzheimer's associations. Over a third of Alzheimer Europe's income (37%) came from the pharmaceutical industry in 2005. The biggest payments were from Lundbeck (€51,683 - £35,347), Janssen-Cilag (€40,000) and Pfizer (€39,230). The Alzheimer's Society in the UK accepts far less from drug companies - donations amounted to less than 1% of income in the financial year 2005-06.
- Sarah Boseley, health editor Drug firms and patient groups join in fight to overturn advertising ban Monday May 21, 2007 The Guardian